The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy

Published:2017-08 Issue:8 Volume:8 Page:e2983-e2983
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Xu Dongwei,Chen Lili,Chen Xiaosong,Wen Yankai,Yu Chang,Yao Jufang,Wu Hailong,Wang Xin,Xia Qiang,Kong Xiaoni

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2017386.pdf

Reference39 articles.

1. Khandoga A, Hanschen M, Kessler JS, Krombach F . CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology (Baltimore, Md) 2006; 43: 306–315.

2. Abe Y, Hines I, Zibari G, Grisham MB . Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury. Arch Biochem Biophys 2009; 484: 232–237.

3. Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW . Ischaemia-reperfusion injury in liver transplantation—from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10: 79–89.

4. Kensler TW, Wakabayashi N, Biswal S . Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Ann Rev Pharmacol Toxicol 2007; 47: 89–116.

5. Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P et al. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am J Respir Crit Care Med 2011; 184: 928–938.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blockade of the mitochondrial DNA release ameliorates hepatic ischemia-reperfusion injury through avoiding the activation of cGAS-Sting pathway;Journal of Translational Medicine;2024-08-28

2. Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway;International Journal of Chronic Obstructive Pulmonary Disease;2024-08

3. CRHR1 antagonist alleviated depression-like behavior by downregulating p62 in a rat model of post-stroke depression;Experimental Neurology;2024-08

4. Programmed cell death, from liver Ischemia–Reperfusion injury perspective: An overview;Heliyon;2024-07

5. Mitochondrial dysfunction: A promising therapeutic target for liver diseases;Genes & Diseases;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3